• Yellow Card reporting for patient safety in NI• Non Medical Prescribers working in General Practice• NICE Guidance (Recently Published)• Managed Entry Decisions• Deprescribing social media campaigns• Deprescribe: Benzodiazepines and Z-drugs• Deprescribe: Short Acting Beta Agonists (SABAs) for asthmaNon Medical
• Isotretinoin (Roaccutane®): introduction of new safety measures• Ketamine and octreotide in palliative care• NICE Guidance Recently published / withdrawn• Managed Entry Decisions• Reminder – Bath and shower emollients removed from NI Formulary• Deprescribe: Oral nutritional supplement
• Folic acid use in pregnancy and pre-conception• Category 3 antiepileptics questionnaire• ACP webinars and workshop: Nutrition• NICE Guidance Recently published / Not recommended• Managed Entry Decisions• Management of Vaginal Atrophy• Deprescribe: Preparations for allergic rhinitis
Non–pharmacological management; Pharmacological management: Management of refractory symptoms; Continuing or stepping down treatment; Referral for specialist assessment
• Be aware of similar named oral nutritional supplements• Supply of liquid dose measures for all patients, including adults• NICE Guidance Recently published / Withdrawn• Managed Entry Decisions• Reducing opioid use in chronic non-cancer pain• Deprescribe: Propranolol for anxiety
• Metformin: If not, why not? New resources available• Use the most cost effective formulation of metformin• Care when using Tresiba 200u/ml Flextouch®pen• Sitagliptin is now first line DPP4 inhibitor• Prevention and management of hypoglycaemia • Cardiovascular Risk Management in Type 2 Diabetes• Deprescribing in the frail elderly with diabetes• Shortages and discontinuations of drugs to manage blood glucose
•Coroner alert: Death caused by Oxycodone and Pregabalin Toxicity• NICE Guidance Recently published• Managed Entry Decisions• Clozapine & Potential Serious GI Side Effects• Deprescribe: antibiotics for UTI prevention
• New data collection forms for network activity• Introducing the Marie Curie Daffodil standards• Palliative Care resources, clinical information and feedback• Addressing issues raised at the Network ECHO talk• Contact details for Network co-ordinator
Reminder: adrenaline stock prescribing for the treatment of anaphylaxis in Primary Care; Important Prescribing Changes for Tegretol®100mg/5ml liquid; NICE Guidance Recently published / Withdrawn; Managed Entry Decisions; Mycophenolate Shared Care Guideline Update; Deprescribe: Proton pump inhibitors (PPIs
